D)etection of prion proteini in formiialin-fixed brain bNs hs drated autoclaving imllmUnohistochernistry for the diagnlosis of scrapic in sheep. Jouira1()l of ' tcrilnarr L)iagnostic hil,cstigation 6, 366-368 OIE (2000) Bovine spongifornii encephalopathy. In MlanlLial of Stanldards for I)i.agnostic Tests anid accicnes. 4th edni. Paris, Office Ilternlatiolnal des [pizooties. pp 457-466
Soluble Fms-like tyrosine kinase (sFlt-1/sVEGFR1) is a natural occurring antagonist of vascular endothelial growth factor (VEGF). Despite being a secreted, soluble protein lacking cytoplasmic and transmembrane domains, sFlt-1 can act locally and be protective against excessive microenvironmental VEGF concentration, or exert autocrine functions independently of VEGF. Circulating sFlt-1 may indiscriminately affect endothelial function and the microvasculature on distant target organs. The clinical significance of excess sFlt-1 in kidney disease was first shown in preeclampsia, a major renal complication of pregnancy. However, circulating sFlt-1 levels appear to be increased in different diseases with varying degrees of renal impairment. Relevant clinical associations between circulating sFlt-1 and severe outcomes (e.g., endothelial dysfunction, renal impairment, cardiovascular disease, and all-cause mortality) have been observed in patients with chronic kidney disease and following kidney transplantation. However, sFlt-1 appears to be protective against renal dysfunction-associated aggravation of atherosclerosis and diabetic nephropathy. Therefore, in this review, we provide an update on sFlt-1 in several kidney diseases other than preeclampsia, discuss clinical findings and experimental studies, and briefly consider its use in clinical practice.
In KTR, uEGF/Cr ratio is independently and inversely associated with the risk of graft failure and depicts strong prediction ability for this outcome. Further studies seem warranted to elucidate whether uEGF might be a promising biomarker for clinical uptake postkidney transplantation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.